Global Non-Invasive Drug Delivery Market Growth 2023-2028

Report ID: 1290799 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Non-Invasive Drug Delivery Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Non-Invasive Drug Delivery by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Non-Invasive Drug Delivery by Country/Region, 2017, 2022 & 2028
    2.2 Non-Invasive Drug Delivery Segment by Type
        2.2.1 Artificial Pancreas
        2.2.2 Needle Free Injector
        2.2.3 Digital Respiratory Devices
        2.2.4 Other
    2.3 Non-Invasive Drug Delivery Sales by Type
        2.3.1 Global Non-Invasive Drug Delivery Sales Market Share by Type (2017-2022)
        2.3.2 Global Non-Invasive Drug Delivery Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Non-Invasive Drug Delivery Sale Price by Type (2017-2022)
    2.4 Non-Invasive Drug Delivery Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
        2.4.3 Other
    2.5 Non-Invasive Drug Delivery Sales by Application
        2.5.1 Global Non-Invasive Drug Delivery Sale Market Share by Application (2017-2022)
        2.5.2 Global Non-Invasive Drug Delivery Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Non-Invasive Drug Delivery Sale Price by Application (2017-2022)
3 Global Non-Invasive Drug Delivery by Company
    3.1 Global Non-Invasive Drug Delivery Breakdown Data by Company
        3.1.1 Global Non-Invasive Drug Delivery Annual Sales by Company (2020-2022)
        3.1.2 Global Non-Invasive Drug Delivery Sales Market Share by Company (2020-2022)
    3.2 Global Non-Invasive Drug Delivery Annual Revenue by Company (2020-2022)
        3.2.1 Global Non-Invasive Drug Delivery Revenue by Company (2020-2022)
        3.2.2 Global Non-Invasive Drug Delivery Revenue Market Share by Company (2020-2022)
    3.3 Global Non-Invasive Drug Delivery Sale Price by Company
    3.4 Key Manufacturers Non-Invasive Drug Delivery Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Non-Invasive Drug Delivery Product Location Distribution
        3.4.2 Players Non-Invasive Drug Delivery Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Invasive Drug Delivery by Geographic Region
    4.1 World Historic Non-Invasive Drug Delivery Market Size by Geographic Region (2017-2022)
        4.1.1 Global Non-Invasive Drug Delivery Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Non-Invasive Drug Delivery Annual Revenue by Geographic Region
    4.2 World Historic Non-Invasive Drug Delivery Market Size by Country/Region (2017-2022)
        4.2.1 Global Non-Invasive Drug Delivery Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Non-Invasive Drug Delivery Annual Revenue by Country/Region
    4.3 Americas Non-Invasive Drug Delivery Sales Growth
    4.4 APAC Non-Invasive Drug Delivery Sales Growth
    4.5 Europe Non-Invasive Drug Delivery Sales Growth
    4.6 Middle East & Africa Non-Invasive Drug Delivery Sales Growth
5 Americas
    5.1 Americas Non-Invasive Drug Delivery Sales by Country
        5.1.1 Americas Non-Invasive Drug Delivery Sales by Country (2017-2022)
        5.1.2 Americas Non-Invasive Drug Delivery Revenue by Country (2017-2022)
    5.2 Americas Non-Invasive Drug Delivery Sales by Type
    5.3 Americas Non-Invasive Drug Delivery Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Non-Invasive Drug Delivery Sales by Region
        6.1.1 APAC Non-Invasive Drug Delivery Sales by Region (2017-2022)
        6.1.2 APAC Non-Invasive Drug Delivery Revenue by Region (2017-2022)
    6.2 APAC Non-Invasive Drug Delivery Sales by Type
    6.3 APAC Non-Invasive Drug Delivery Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Non-Invasive Drug Delivery by Country
        7.1.1 Europe Non-Invasive Drug Delivery Sales by Country (2017-2022)
        7.1.2 Europe Non-Invasive Drug Delivery Revenue by Country (2017-2022)
    7.2 Europe Non-Invasive Drug Delivery Sales by Type
    7.3 Europe Non-Invasive Drug Delivery Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Non-Invasive Drug Delivery by Country
        8.1.1 Middle East & Africa Non-Invasive Drug Delivery Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Non-Invasive Drug Delivery Revenue by Country (2017-2022)
    8.2 Middle East & Africa Non-Invasive Drug Delivery Sales by Type
    8.3 Middle East & Africa Non-Invasive Drug Delivery Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Non-Invasive Drug Delivery
    10.3 Manufacturing Process Analysis of Non-Invasive Drug Delivery
    10.4 Industry Chain Structure of Non-Invasive Drug Delivery
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Non-Invasive Drug Delivery Distributors
    11.3 Non-Invasive Drug Delivery Customer
12 World Forecast Review for Non-Invasive Drug Delivery by Geographic Region
    12.1 Global Non-Invasive Drug Delivery Market Size Forecast by Region
        12.1.1 Global Non-Invasive Drug Delivery Forecast by Region (2023-2028)
        12.1.2 Global Non-Invasive Drug Delivery Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Non-Invasive Drug Delivery Forecast by Type
    12.7 Global Non-Invasive Drug Delivery Forecast by Application
13 Key Players Analysis
    13.1 Adherium Limited
        13.1.1 Adherium Limited Company Information
        13.1.2 Adherium Limited Non-Invasive Drug Delivery Product Offered
        13.1.3 Adherium Limited Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Adherium Limited Main Business Overview
        13.1.5 Adherium Limited Latest Developments
    13.2 Capsule Technologies, Inc.
        13.2.1 Capsule Technologies, Inc. Company Information
        13.2.2 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Offered
        13.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Capsule Technologies, Inc. Main Business Overview
        13.2.5 Capsule Technologies, Inc. Latest Developments
    13.3 Crossject S.A.
        13.3.1 Crossject S.A. Company Information
        13.3.2 Crossject S.A. Non-Invasive Drug Delivery Product Offered
        13.3.3 Crossject S.A. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Crossject S.A. Main Business Overview
        13.3.5 Crossject S.A. Latest Developments
    13.4 Diabeloop SA
        13.4.1 Diabeloop SA Company Information
        13.4.2 Diabeloop SA Non-Invasive Drug Delivery Product Offered
        13.4.3 Diabeloop SA Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Diabeloop SA Main Business Overview
        13.4.5 Diabeloop SA Latest Developments
    13.5 HNS International, Inc.
        13.5.1 HNS International, Inc. Company Information
        13.5.2 HNS International, Inc. Non-Invasive Drug Delivery Product Offered
        13.5.3 HNS International, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 HNS International, Inc. Main Business Overview
        13.5.5 HNS International, Inc. Latest Developments
    13.6 Inovio Pharmaceuticals, Inc.
        13.6.1 Inovio Pharmaceuticals, Inc. Company Information
        13.6.2 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Offered
        13.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Inovio Pharmaceuticals, Inc. Main Business Overview
        13.6.5 Inovio Pharmaceuticals, Inc. Latest Developments
    13.7 Medtronic Plc.
        13.7.1 Medtronic Plc. Company Information
        13.7.2 Medtronic Plc. Non-Invasive Drug Delivery Product Offered
        13.7.3 Medtronic Plc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Medtronic Plc. Main Business Overview
        13.7.5 Medtronic Plc. Latest Developments
    13.8 Novartis AG
        13.8.1 Novartis AG Company Information
        13.8.2 Novartis AG Non-Invasive Drug Delivery Product Offered
        13.8.3 Novartis AG Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Novartis AG Main Business Overview
        13.8.5 Novartis AG Latest Developments
    13.9 PenJet Corporation
        13.9.1 PenJet Corporation Company Information
        13.9.2 PenJet Corporation Non-Invasive Drug Delivery Product Offered
        13.9.3 PenJet Corporation Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 PenJet Corporation Main Business Overview
        13.9.5 PenJet Corporation Latest Developments
    13.10 PharmaJet
        13.10.1 PharmaJet Company Information
        13.10.2 PharmaJet Non-Invasive Drug Delivery Product Offered
        13.10.3 PharmaJet Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 PharmaJet Main Business Overview
        13.10.5 PharmaJet Latest Developments
    13.11 Portal Instruments
        13.11.1 Portal Instruments Company Information
        13.11.2 Portal Instruments Non-Invasive Drug Delivery Product Offered
        13.11.3 Portal Instruments Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Portal Instruments Main Business Overview
        13.11.5 Portal Instruments Latest Developments
    13.12 ResMed
        13.12.1 ResMed Company Information
        13.12.2 ResMed Non-Invasive Drug Delivery Product Offered
        13.12.3 ResMed Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 ResMed Main Business Overview
        13.12.5 ResMed Latest Developments
    13.13 Sensiron AG
        13.13.1 Sensiron AG Company Information
        13.13.2 Sensiron AG Non-Invasive Drug Delivery Product Offered
        13.13.3 Sensiron AG Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Sensiron AG Main Business Overview
        13.13.5 Sensiron AG Latest Developments
    13.14 Tandem Diabetes Care, Inc.
        13.14.1 Tandem Diabetes Care, Inc. Company Information
        13.14.2 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Offered
        13.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Tandem Diabetes Care, Inc. Main Business Overview
        13.14.5 Tandem Diabetes Care, Inc. Latest Developments
    13.15 Teva Pharmaceuticals Industries Ltd.
        13.15.1 Teva Pharmaceuticals Industries Ltd. Company Information
        13.15.2 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Offered
        13.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Teva Pharmaceuticals Industries Ltd. Main Business Overview
        13.15.5 Teva Pharmaceuticals Industries Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Non-Invasive Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Non-Invasive Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Artificial Pancreas
    Table 4. Major Players of Needle Free Injector
    Table 5. Major Players of Digital Respiratory Devices
    Table 6. Major Players of Other
    Table 7. Global Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 8. Global Non-Invasive Drug Delivery Sales Market Share by Type (2017-2022)
    Table 9. Global Non-Invasive Drug Delivery Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2022)
    Table 11. Global Non-Invasive Drug Delivery Sale Price by Type (2017-2022) & (US$/Unit)
    Table 12. Global Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 13. Global Non-Invasive Drug Delivery Sales Market Share by Application (2017-2022)
    Table 14. Global Non-Invasive Drug Delivery Revenue by Application (2017-2022)
    Table 15. Global Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2022)
    Table 16. Global Non-Invasive Drug Delivery Sale Price by Application (2017-2022) & (US$/Unit)
    Table 17. Global Non-Invasive Drug Delivery Sales by Company (2020-2022) & (K Units)
    Table 18. Global Non-Invasive Drug Delivery Sales Market Share by Company (2020-2022)
    Table 19. Global Non-Invasive Drug Delivery Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Non-Invasive Drug Delivery Revenue Market Share by Company (2020-2022)
    Table 21. Global Non-Invasive Drug Delivery Sale Price by Company (2020-2022) & (US$/Unit)
    Table 22. Key Manufacturers Non-Invasive Drug Delivery Producing Area Distribution and Sales Area
    Table 23. Players Non-Invasive Drug Delivery Products Offered
    Table 24. Non-Invasive Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Non-Invasive Drug Delivery Sales by Geographic Region (2017-2022) & (K Units)
    Table 28. Global Non-Invasive Drug Delivery Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Non-Invasive Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Non-Invasive Drug Delivery Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Non-Invasive Drug Delivery Sales by Country/Region (2017-2022) & (K Units)
    Table 32. Global Non-Invasive Drug Delivery Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Non-Invasive Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Non-Invasive Drug Delivery Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 36. Americas Non-Invasive Drug Delivery Sales Market Share by Country (2017-2022)
    Table 37. Americas Non-Invasive Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Non-Invasive Drug Delivery Revenue Market Share by Country (2017-2022)
    Table 39. Americas Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 40. Americas Non-Invasive Drug Delivery Sales Market Share by Type (2017-2022)
    Table 41. Americas Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 42. Americas Non-Invasive Drug Delivery Sales Market Share by Application (2017-2022)
    Table 43. APAC Non-Invasive Drug Delivery Sales by Region (2017-2022) & (K Units)
    Table 44. APAC Non-Invasive Drug Delivery Sales Market Share by Region (2017-2022)
    Table 45. APAC Non-Invasive Drug Delivery Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Non-Invasive Drug Delivery Revenue Market Share by Region (2017-2022)
    Table 47. APAC Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 48. APAC Non-Invasive Drug Delivery Sales Market Share by Type (2017-2022)
    Table 49. APAC Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 50. APAC Non-Invasive Drug Delivery Sales Market Share by Application (2017-2022)
    Table 51. Europe Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 52. Europe Non-Invasive Drug Delivery Sales Market Share by Country (2017-2022)
    Table 53. Europe Non-Invasive Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Non-Invasive Drug Delivery Revenue Market Share by Country (2017-2022)
    Table 55. Europe Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 56. Europe Non-Invasive Drug Delivery Sales Market Share by Type (2017-2022)
    Table 57. Europe Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 58. Europe Non-Invasive Drug Delivery Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 60. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Non-Invasive Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Non-Invasive Drug Delivery Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 64. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 66. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Non-Invasive Drug Delivery
    Table 68. Key Market Challenges & Risks of Non-Invasive Drug Delivery
    Table 69. Key Industry Trends of Non-Invasive Drug Delivery
    Table 70. Non-Invasive Drug Delivery Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Non-Invasive Drug Delivery Distributors List
    Table 73. Non-Invasive Drug Delivery Customer List
    Table 74. Global Non-Invasive Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
    Table 75. Global Non-Invasive Drug Delivery Sales Market Forecast by Region
    Table 76. Global Non-Invasive Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Non-Invasive Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Non-Invasive Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
    Table 79. Americas Non-Invasive Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Non-Invasive Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. APAC Non-Invasive Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Non-Invasive Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Europe Non-Invasive Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Non-Invasive Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
    Table 85. Middle East & Africa Non-Invasive Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Non-Invasive Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)
    Table 87. Global Non-Invasive Drug Delivery Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Non-Invasive Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Non-Invasive Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Non-Invasive Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)
    Table 91. Global Non-Invasive Drug Delivery Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global Non-Invasive Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global Non-Invasive Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Adherium Limited Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 95. Adherium Limited Non-Invasive Drug Delivery Product Offered
    Table 96. Adherium Limited Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 97. Adherium Limited Main Business
    Table 98. Adherium Limited Latest Developments
    Table 99. Capsule Technologies, Inc. Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 100. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Offered
    Table 101. Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 102. Capsule Technologies, Inc. Main Business
    Table 103. Capsule Technologies, Inc. Latest Developments
    Table 104. Crossject S.A. Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 105. Crossject S.A. Non-Invasive Drug Delivery Product Offered
    Table 106. Crossject S.A. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 107. Crossject S.A. Main Business
    Table 108. Crossject S.A. Latest Developments
    Table 109. Diabeloop SA Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 110. Diabeloop SA Non-Invasive Drug Delivery Product Offered
    Table 111. Diabeloop SA Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 112. Diabeloop SA Main Business
    Table 113. Diabeloop SA Latest Developments
    Table 114. HNS International, Inc. Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 115. HNS International, Inc. Non-Invasive Drug Delivery Product Offered
    Table 116. HNS International, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 117. HNS International, Inc. Main Business
    Table 118. HNS International, Inc. Latest Developments
    Table 119. Inovio Pharmaceuticals, Inc. Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 120. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Offered
    Table 121. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 122. Inovio Pharmaceuticals, Inc. Main Business
    Table 123. Inovio Pharmaceuticals, Inc. Latest Developments
    Table 124. Medtronic Plc. Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 125. Medtronic Plc. Non-Invasive Drug Delivery Product Offered
    Table 126. Medtronic Plc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 127. Medtronic Plc. Main Business
    Table 128. Medtronic Plc. Latest Developments
    Table 129. Novartis AG Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 130. Novartis AG Non-Invasive Drug Delivery Product Offered
    Table 131. Novartis AG Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 132. Novartis AG Main Business
    Table 133. Novartis AG Latest Developments
    Table 134. PenJet Corporation Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 135. PenJet Corporation Non-Invasive Drug Delivery Product Offered
    Table 136. PenJet Corporation Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 137. PenJet Corporation Main Business
    Table 138. PenJet Corporation Latest Developments
    Table 139. PharmaJet Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 140. PharmaJet Non-Invasive Drug Delivery Product Offered
    Table 141. PharmaJet Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 142. PharmaJet Main Business
    Table 143. PharmaJet Latest Developments
    Table 144. Portal Instruments Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 145. Portal Instruments Non-Invasive Drug Delivery Product Offered
    Table 146. Portal Instruments Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 147. Portal Instruments Main Business
    Table 148. Portal Instruments Latest Developments
    Table 149. ResMed Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 150. ResMed Non-Invasive Drug Delivery Product Offered
    Table 151. ResMed Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 152. ResMed Main Business
    Table 153. ResMed Latest Developments
    Table 154. Sensiron AG Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 155. Sensiron AG Non-Invasive Drug Delivery Product Offered
    Table 156. Sensiron AG Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 157. Sensiron AG Main Business
    Table 158. Sensiron AG Latest Developments
    Table 159. Tandem Diabetes Care, Inc. Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 160. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Offered
    Table 161. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 162. Tandem Diabetes Care, Inc. Main Business
    Table 163. Tandem Diabetes Care, Inc. Latest Developments
    Table 164. Teva Pharmaceuticals Industries Ltd. Basic Information, Non-Invasive Drug Delivery Manufacturing Base, Sales Area and Its Competitors
    Table 165. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Offered
    Table 166. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 167. Teva Pharmaceuticals Industries Ltd. Main Business
    Table 168. Teva Pharmaceuticals Industries Ltd. Latest Developments
List of Figures
    Figure 1. Picture of Non-Invasive Drug Delivery
    Figure 2. Non-Invasive Drug Delivery Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Non-Invasive Drug Delivery Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Non-Invasive Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Non-Invasive Drug Delivery Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Artificial Pancreas
    Figure 10. Product Picture of Needle Free Injector
    Figure 11. Product Picture of Digital Respiratory Devices
    Figure 12. Product Picture of Other
    Figure 13. Global Non-Invasive Drug Delivery Sales Market Share by Type in 2021
    Figure 14. Global Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2022)
    Figure 15. Non-Invasive Drug Delivery Consumed in Hospital
    Figure 16. Global Non-Invasive Drug Delivery Market: Hospital (2017-2022) & (K Units)
    Figure 17. Non-Invasive Drug Delivery Consumed in Clinic
    Figure 18. Global Non-Invasive Drug Delivery Market: Clinic (2017-2022) & (K Units)
    Figure 19. Non-Invasive Drug Delivery Consumed in Other
    Figure 20. Global Non-Invasive Drug Delivery Market: Other (2017-2022) & (K Units)
    Figure 21. Global Non-Invasive Drug Delivery Sales Market Share by Application (2017-2022)
    Figure 22. Global Non-Invasive Drug Delivery Revenue Market Share by Application in 2021
    Figure 23. Non-Invasive Drug Delivery Revenue Market by Company in 2021 ($ Million)
    Figure 24. Global Non-Invasive Drug Delivery Revenue Market Share by Company in 2021
    Figure 25. Global Non-Invasive Drug Delivery Sales Market Share by Geographic Region (2017-2022)
    Figure 26. Global Non-Invasive Drug Delivery Revenue Market Share by Geographic Region in 2021
    Figure 27. Global Non-Invasive Drug Delivery Sales Market Share by Region (2017-2022)
    Figure 28. Global Non-Invasive Drug Delivery Revenue Market Share by Country/Region in 2021
    Figure 29. Americas Non-Invasive Drug Delivery Sales 2017-2022 (K Units)
    Figure 30. Americas Non-Invasive Drug Delivery Revenue 2017-2022 ($ Millions)
    Figure 31. APAC Non-Invasive Drug Delivery Sales 2017-2022 (K Units)
    Figure 32. APAC Non-Invasive Drug Delivery Revenue 2017-2022 ($ Millions)
    Figure 33. Europe Non-Invasive Drug Delivery Sales 2017-2022 (K Units)
    Figure 34. Europe Non-Invasive Drug Delivery Revenue 2017-2022 ($ Millions)
    Figure 35. Middle East & Africa Non-Invasive Drug Delivery Sales 2017-2022 (K Units)
    Figure 36. Middle East & Africa Non-Invasive Drug Delivery Revenue 2017-2022 ($ Millions)
    Figure 37. Americas Non-Invasive Drug Delivery Sales Market Share by Country in 2021
    Figure 38. Americas Non-Invasive Drug Delivery Revenue Market Share by Country in 2021
    Figure 39. United States Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Canada Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Mexico Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Brazil Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 43. APAC Non-Invasive Drug Delivery Sales Market Share by Region in 2021
    Figure 44. APAC Non-Invasive Drug Delivery Revenue Market Share by Regions in 2021
    Figure 45. China Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Japan Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 47. South Korea Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Southeast Asia Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 49. India Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Australia Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Europe Non-Invasive Drug Delivery Sales Market Share by Country in 2021
    Figure 52. Europe Non-Invasive Drug Delivery Revenue Market Share by Country in 2021
    Figure 53. Germany Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 54. France Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 55. UK Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Italy Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Russia Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Country in 2021
    Figure 59. Middle East & Africa Non-Invasive Drug Delivery Revenue Market Share by Country in 2021
    Figure 60. Egypt Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 61. South Africa Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Israel Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Turkey Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 64. GCC Country Non-Invasive Drug Delivery Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Manufacturing Cost Structure Analysis of Non-Invasive Drug Delivery in 2021
    Figure 66. Manufacturing Process Analysis of Non-Invasive Drug Delivery
    Figure 67. Industry Chain Structure of Non-Invasive Drug Delivery
    Figure 68. Channels of Distribution
    Figure 69. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Non-Invasive Drug Delivery Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Non-Invasive Drug Delivery Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Non-Invasive Drug Delivery Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports